Indication
Gastritis
14 clinical trials
23 products
1 drug
Product
DA-5219Product
StillenClinical trial
A Multicenter, Randomized, Double-blind, Active-controlled, Parallel, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic GastritisStatus: Recruiting, Estimated PCD: 2024-12-01
Clinical trial
Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab. in Korean Patients With Acute or Chronic Gastritis in Accordance With Korean Regulation, 'Standard for Re-examination of New Drugs'Status: Recruiting, Estimated PCD: 2024-12-15
Product
Mucosta SRClinical trial
Randomized, Double-Blind, Placebo-Controlled Trial of Meriva® (Curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisStatus: Active (not recruiting), Estimated PCD: 2022-10-06
Product
CurcuminClinical trial
To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology (CGDP) in Schoolchildren in the Primary Health Care System.Status: Active (not recruiting), Estimated PCD: 2025-12-30
Product
Enteral oxygen therapyClinical trial
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal MicroecologyStatus: Recruiting, Estimated PCD: 2023-12-02
Product
EsomeprazoleProduct
AmoxicillinProduct
BismuthProduct
ClarithromycinClinical trial
Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic GastritisStatus: Active (not recruiting), Estimated PCD: 2025-04-01
Product
Mononuclear cellsClinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Recruiting, Estimated PCD: 2024-06-06
Product
VonoprazanProduct
amoxicillinProduct
TetracyclineProduct
FurazolidoneClinical trial
Clinical Study on the Efficacy of Modified Liujunzi Prescription on the Treatment of Atrophic Gastritis After HP EradicationStatus: Recruiting, Estimated PCD: 2024-12-31
Product
MLDProduct
WFCClinical trial
Rescue Therapy for Helicobacter Pylori Eradication: A Randomized and Non-inferiority Trail of High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple TherapyStatus: Completed, Estimated PCD: 2021-12-20
Clinical trial
Efficacy and Safety of Berberine Hydrochloride, Amoxicillin and Rabeprazole Triple Therapy in the First Eradication of Helicobacter PyloriStatus: Completed, Estimated PCD: 2021-12-20
Product
BerberineProduct
RabeprazoleClinical trial
Study on The Efficacy and Safety of Berberine,Amoxicillin and Vonoprazan Containing Triple Therapy in Helicobacter Pylori First-Line EradicationStatus: Completed, Estimated PCD: 2022-03-31
Clinical trial
Protective Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary InterventionStatus: Completed, Estimated PCD: 2018-12-01
Product
ALBISDrug
VarlilumabClinical trial
Randomized, Double-Blind, Placebo-Controlled, Non-inferiority Clinical Trial on the Efficacy and Safety of Houtou Jianweiling Tablet in the Treatment of Chronic Non-Atrophic GastritisStatus: Completed, Estimated PCD: 2023-02-02
Product
OmeprazoleClinical trial
A Multi-center, Open-label, Randomized, Phase IV Clinical Trial to Compare the Efficacy and Safety of Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With GastritisStatus: Completed, Estimated PCD: 2022-12-15
Product
Mucotra SRProduct
Axid